Lisinopril
Brands: Zestril · Lisinopril
32 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 160 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Zestril · Lisinopril
Average across 160 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Exelan Pharmaceuticals Inc. | unknown | 88 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 65 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 62 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 47 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 47 | SUPPLYING |
| Proficient Rx LP | repackager | 45 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 43 | SUPPLYING |
| A-S Medication Solutions | repackager | 39 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 31 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 28 | SUPPLYING |
| XLCare Pharmaceuticals Inc. | unknown | 24 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 20 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 20 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 18 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 18 | SUPPLYING |
+ 18 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet. — Recalling firm: Evaric Pharmaceuticals Inc. — Nationwide in the USA
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots — Recalling firm: NCS Healthcare of Kentucky Inc — Nationwide USA
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors/wholesalers nationwide.
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to OH and may have been further distributed throughout the United States.
Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the US.
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets. — Recalling firm: Lupin Pharmaceuticals Inc. — U.S.A. Nationwide
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Pharmaceuticals Inc. — All product distributed domestically in the US. No recalled product was distributed to U.S. Government Agency consignee…
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Pharmaceuticals Inc. — All product distributed domestically in the US. No recalled product was distributed to U.S. Government Agency consignee…